Rxq Compounding recalls
Rxq Compounding appears in 88 official U.S. recall notices indexed by RecallRadar.
Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.
- ONDANSETRON 2 MG/ML INJECTION SOLUTION (NPF), 20ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - RXQ CAIN (PHENYLEP 1.5%/ LIDO 1% OPHTH SOL (PF), 1 ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - RIBOFLAVIN 0.1% OPHTHALMIC SOLUTION SYRINGE, 2 ML per syringe
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - SUCCINYLCHOLINE CHLORIDE 20MG/ML INJ SOL, 10 ML per Vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - EPHEDRINE 5MG/ML (PF) SYRINGE, 5 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - LIDOCAINE 0.75%/Epinephrine 0.025%/BSS 0.56ML SYR, 1 ML PER Syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - Ascorbic Acid 400 MG/ML (Non-Corn) Injection Solution, 65 mL per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Crystallization - METHYLCOBALAMIN 1 MG/ML (MDV) INJECTABLE SOLUTION, 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - ZINC SULFATE 1MG/ML INJECTION SOLUTION, 30ML per VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - TURBO CAINE 2.5 (PHEN2.5/CYCLO1/ TROP1/TETRA 0.5), 0.4 ML per Syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - TURBO DROPS (PHEN 2.5% / CYCLO 1%/ TROP 1%/ KETO 0.5%) OPHTH SOLN, 5 ML per dropper bottle, RXQ Compounding, 340 West State Street, Unit 9,…
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - CALCIUM CHLORIDE 100MG/ML (PFV) INJ SOLN, 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - EDETATE CALCIUM DISODIUM 150MG/ML INJECTABLE, 100 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - HYDROGEN PEROXIDE 3% INJECTABLE PFV, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - TAURINE 50 MG/ML (MDV) INJECTABLE, 30 ML per Vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - PREDNISOLONE 1%, MOXIFLOXACIN 0.5% OPHTH SOL, 5ML per dropper bottle, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - DEXTROSE 50% INJECTION SOLUTION (PF) SYRINGE, 50 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - MAGNESIUM CHLORIDE HEXAHYDRATE (MDV) 20% INJ SOLN, 50 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - KETAMINE 50 MG/ML (NPV) INJECTION SOLUTION (C-III), 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - EPINEPHrine 4MG ADDED TO D5W 5%, 250 ML per bag, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - EPINEPHrine 1:1000 INJECTION SOLUTION (PF) Syringe, 1 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - EDETATE DISODIUM 30% INJECTABLE, 100 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - STERILE WATER FOR INJECTION USP, [10, 30, or 50 ML] per Vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - SOD-PHOS (PHOS 3MMOL/ML-SOD 4MEQ/ML) PFV INJ SOLN, 10 ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - NEOSTIGMINE METHYL SULFATE 1MG/ML INJ SOL SYR, 5 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - Ascorbic Acid 500 MG/ML (Non-Corn) INJ (MDV), 50 mL per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Crystallization - METHYLCOBALAMIN 10MG/ML INJECTABLE SOLUTION (MDV), 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - Copper 0.4MG/ML (PVF) INJECTION SOLUTION, 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - SODIUM BICARBONATE 8.4% (1 MEQ/ML) INJ SOLN (PFV), 50 ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - FOLIC ACID 10MG/ML INJECTION SOLUTION (MDV), 5 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - CYANCOBALAMIN 1200MCG/ML MDV INJECTION, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - NIACINAMIDE 100MG/ML, 10ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - PHENYLEPHRINE HCL 100 MCG/ML IN NACL 0.9% SYR, 10 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - ROPIVICAINE 0.2%, INJ SOLN, 550 ML ON-Q PUMP. RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - GLUTATHIONE 200MG/ML (MDV) INJECTION SOLN, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - ONDANSETRON 2 MG/ML INJECTION SOLUTION (PFV), 2 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2019-08-14 · Rxq Compounding
Reason: Lack of Assurance of Sterility - Lidocaine 1% + Epinephrine 1:100,000 (MDV) INJ SOL, 50 mL per glass vial, Rx only, 340 West State Street, Unit 9, Athens, OH 45701
FDA Drug · Class II · 2018-10-31 · Rxq Compounding
Reason: Subpotent drug: During testing of the retention sample, the firm discovered that the product was sub-potent. - methylPREDNIsolone ACETATE, 40 MG/ML INJECTION SUSPENSION, 10 ML Vial, RXQ Compounding, Athens, OH --- NDC: 70731-0936-10
FDA Drug · Class II · 2017-10-25 · Rxq Compounding
Reason: Lack of Assurance of Sterility; autoclave parameters were not correct for one of two autoclaves used to sterilize the product.